Naomi B. Haas

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma

Toni K. Choueiri, Piotr Tomczak, Se Hoon Park et al. · New England Journal of Medicine · 2021 · 708 citations · Full text

Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

A.S. Lübbe, Christian Bergemann, Hanno Riess et al. · PubMed · 1996 · 653 citations

Magnetic Fluids, Pharmacotherapy, Advanced Solid Tumors +16

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal et al. · Journal of the National Comprehensive Cancer Network · 2022 · 627 citations · Full text

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

Naomi B. Haas, Judith Manola, Robert G. Uzzo et al. · The Lancet · 2016 · 625 citations · Full text

Urology, Genitourinary Cancer, Medicine +8

Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation

Joyce V. Lee, Alessandro Carrer, Supriya Shah et al. · Cell Metabolism · 2014 · 566 citations · Full text

Chromatin, Chromatin Remodeling, Metabolic Reprogramming +5